TG Therapeutics, Inc.
IT ˙ BIT ˙ US88322Q1085
34,00 € 0,00 (0,00%)
2026-06-05
DEL PRIS
SecurityIT:1TGTX / TG Therapeutics, Inc.
InstitutionMillennium Management Llc
ManagerIsrael Englander
Latest Disclosed Ownership122,587 shares
Latest Disclosed Value $ 4,072,340
Millennium Management Llc ownership in 1TGTX / TG Therapeutics, Inc.

On May 15, 2026 - Millennium Management Llc filed a 13F-HR form disclosing ownership of 122,587 shares of TG Therapeutics, Inc. (IT:1TGTX) valued at $3,390,756 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 675,910 shares of TG Therapeutics, Inc.. This represents a change in shares of -81.86% during the quarter. The current value of the position is $4,167,958 USD.

Millennium Management Llc has a history of taking positions in derivatives of the underlying security (1TGTX) in the form of stock options. The firm currently holds call options representing 38,300 of underlying shares valued at $1,272,326 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

IT:1TGTX / TG Therapeutics, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F TG THERAPEUTICS COM 88322Q108 122,587 -553,323 -81.86 4,072 -79.79 0.0017
2026-02-17 2025-12-31 13F TG THERAPEUTICS COM 88322Q108 675,910 385,023 132.36 20,149 91.74 0.0085
2025-11-14 2025-09-30 13F TG THERAPEUTICS COM 88322Q108 290,887 -324,846 -52.76 10,508 -52.58 0.0045
2025-08-14 2025-06-30 13F TG THERAPEUTICS COM 88322Q108 615,733 525,997 586.16 22,160 526.34 0.0107
2025-05-15 2025-03-31 13F TG THERAPEUTICS COM 88322Q108 89,736 89,736 3,538 0.0019
2025-02-14 2024-12-31 13F TG THERAPEUTICS COM 88322Q108 0 -11,794 -100.00 0 -100.00
2024-11-14 2024-09-30 13F TG THERAPEUTICS COM 88322Q108 11,794 -1,446,114 -99.19 276 -98.94 0.0001
2024-08-14 2024-06-30 13F TG THERAPEUTICS COM 88322Q108 1,457,908 -2,026,138 -58.15 25,936 -51.06 0.0120
2024-05-15 2024-03-31 13F TG THERAPEUTICS COM 88322Q108 3,484,046 555,258 18.96 52,992 5.94 0.0226
2024-02-14 2023-12-31 13F TG THERAPEUTICS COM 88322Q108 2,928,788 912,357 45.25 50,024 196.75 0.0216
2023-11-14 2023-09-30 13F TG THERAPEUTICS COM 88322Q108 2,016,431 1,181,301 141.45 16,857 -18.74 0.0085
2023-08-14 2023-06-30 13F TG THERAPEUTICS COM 88322Q108 835,130 -1,791,443 -68.20 20,745 -47.49 0.0102
2023-05-15 2023-03-31 13F TG THERAPEUTICS COM 88322Q108 2,626,573 -3,566,599 -57.59 39,504 -46.08 0.0227
2023-02-14 2022-12-31 13F TG THERAPEUTICS COM 88322Q108 6,193,172 2,230,975 56.31 73,265 212.35 0.0405
2022-11-14 2022-09-30 13F TG THERAPEUTICS COM 88322Q108 3,962,197 -996,355 -20.09 23,456 11.30 0.0139
2022-08-15 2022-06-30 13F TG THERAPEUTICS COM 88322Q108 4,958,552 2,781,903 127.81 21,074 1.81 0.0131
2022-05-16 2022-03-31 13F TG THERAPEUTICS COM 88322Q108 2,176,649 1,640,258 305.80 20,700 103.12 0.0110
2022-02-14 2021-12-31 13F TG THERAPEUTICS COM 88322Q108 536,391 518,633 2,920.56 10,191 1,624.37 0.0052
2021-11-15 2021-09-30 13F TG THERAPEUTICS COM 88322Q108 17,758 -101,456 -85.10 591 -87.22 0.0004
2021-08-16 2021-06-30 13F TG THERAPEUTICS COM 88322Q108 119,214 -197,257 -62.33 4,624 -69.69 0.0028
2021-05-17 2021-03-31 13F TG THERAPEUTICS COM 88322Q108 316,471 -228,105 -41.89 15,254 -46.15 0.0109
2021-02-16 2020-12-31 13F TG THERAPEUTICS COM 88322Q108 544,576 -52,814 -8.84 28,329 77.21 0.0205
2020-11-16 2020-09-30 13F TG THERAPEUTICS COM 88322Q108 597,390 -789,069 -56.91 15,986 -40.81 0.0197
2020-08-14 2020-06-30 13F TG THERAPEUTICS COM 88322Q108 1,386,459 301,818 27.83 27,008 153.05 0.0370
2020-05-14 2020-03-31 13F TG THERAPEUTICS COM 88322Q108 1,084,641 -2,012,402 -64.98 10,673 -68.95 0.0240
2020-02-14 2019-12-31 13F TG THERAPEUTICS COM 88322Q108 3,097,043 -4,424,867 -58.83 34,377 -18.61 0.0430
2019-11-14 2019-09-30 13F TG THERAPEUTICS COM 88322Q108 7,521,910 2,162,051 40.34 42,235 -8.90 0.0668
2019-08-15 2019-06-30 13F/A-1 TG THERAPEUTICS COM 88322Q108 5,359,859 454,073 9.26 46,363 17.54 0.0697
2019-08-14 2019-06-30 13F LOGMEIN COM 88322Q108 118,299 -4,787,487 8,716
2019-05-14 2019-03-31 13F TG THERAPEUTICS COM 88322Q108 4,905,786 4,786,175 4,001.45 39,443 7,949.59 0.0590
2019-02-15 2018-12-31 13F/A-1 TG THERAPEUTICS COM 88322Q108 119,611 -161,704 -57.48 490 -68.89 0.0008
2019-02-14 2018-12-31 13F TG THERAPEUTICS COM 88322Q108 119,611 490
2018-11-14 2018-09-30 13F TG THERAPEUTICS COM 88322Q108 281,315 -244,237 -46.47 1,575 -77.21 0.0019
2018-08-14 2018-06-30 13F TG THERAPEUTICS COM 88322Q108 525,552 135,562 34.76 6,911 24.79 0.0090
2018-05-15 2018-03-31 13F TG THERAPEUTICS COM 88322Q108 389,990 389,990 5,538 0.0074
2018-02-14 2017-12-31 13F TG THERAPEUTICS COM 88322Q108 0 -132,401 -100.00 0 -100.00
2017-11-14 2017-09-30 13F TG THERAPEUTICS COM 88322Q108 132,401 95,027 254.26 1,569 317.29 0.0024
2017-08-14 2017-06-30 13F TG THERAPEUTICS COM 88322Q108 37,374 -153,253 -80.39 376 -83.07 0.0007
2017-05-15 2017-03-31 13F TG THERAPEUTICS COM 88322Q108 190,627 44,901 30.81 2,221 227.58 0.0041
2017-02-14 2016-12-31 13F TG THERAPEUTICS COM 88322Q108 145,726 145,726 0.00 678 0.0014
2016-11-14 2016-09-30 13F TG THERAPEUTICS COM 88322Q108 0 -198,298 -100.00 0 -100.00
2016-08-15 2016-06-30 13F TG THERAPEUTICS COM 88322Q108 198,298 198,298 0.00 1,202 0.0028
2016-05-16 2016-03-31 13F TG THERAPEUTICS COM 88322Q108 0 -158,125 -100.00 0 -100.00
2016-02-16 2015-12-31 13F TG THERAPEUTICS COM 88322Q108 158,125 158,125 0.00 1,886 0.0040
2015-11-16 2015-09-30 13F TG THERAPEUTICS COM 88322Q108 0 -33,587 -100.00 0 -100.00
2015-08-14 2015-06-30 13F TG THERAPEUTICS COM 88322Q108 33,587 -34,390 -50.59 557 -47.05 0.0011
2015-05-15 2015-03-31 13F TG THERAPEUTICS COM 88322Q108 67,977 67,977 0.00 1,052 0.0020
2015-02-17 2014-12-31 13F TG THERAPEUTICS COM 88322Q108 0 -136,877 -100.00 0 -100.00
2014-11-14 2014-09-30 13F TG THERAPEUTICS COM 88322Q108 136,877 -133,845 -49.44 1,460 -42.56 0.0037
2014-08-14 2014-06-30 13F TG THERAPEUTICS COM 88322Q108 270,722 270,722 59.48 2,542 196.96 0.0070
2014-02-14 2013-12-31 13F TG THERAPEUTICS COM 88322Q108 0 -169,749 -100.00 0 -100.00
2013-11-14 2013-09-30 13F TG THERAPEUTICS COM 88322Q108 169,749 169,749 856 0.0028
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F TG THERAPEUTICS COM Call 38,300 1,272 n/a n/a n/a
2025-08-14 2025-06-30 13F TG THERAPEUTICS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2025-05-15 2025-03-31 13F TG THERAPEUTICS COM Call 10,000 394 n/a n/a n/a
2024-05-15 2024-03-31 13F TG THERAPEUTICS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2024-02-14 2023-12-31 13F TG THERAPEUTICS COM Call 181,500 3,100 n/a n/a n/a
2023-11-14 2023-09-30 13F TG THERAPEUTICS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2023-08-14 2023-06-30 13F TG THERAPEUTICS COM Call 101,400 -50.39 2,519 -18.09 n/a n/a n/a
2023-05-15 2023-03-31 13F TG THERAPEUTICS COM Call 204,400 -18.66 3,074 3.40 n/a n/a n/a
2023-02-14 2022-12-31 13F TG THERAPEUTICS COM Call 251,300 25.65 2,973 151.10 n/a n/a n/a
2022-11-14 2022-09-30 13F TG THERAPEUTICS COM Call 200,000 15.87 1,184 61.31 n/a n/a n/a
2022-08-15 2022-06-30 13F TG THERAPEUTICS COM Call 172,600 -42.47 734 -74.27 n/a n/a n/a
2022-05-16 2022-03-31 13F TG THERAPEUTICS COM Call 300,000 262.76 2,853 81.60 n/a n/a n/a
2022-02-14 2021-12-31 13F TG THERAPEUTICS COM Call 82,700 106.75 1,571 18.03 n/a n/a n/a
2021-11-15 2021-09-30 13F TG THERAPEUTICS COM Call 40,000 1,331 n/a n/a n/a
2020-08-14 2020-06-30 13F TG THERAPEUTICS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2020-05-14 2020-03-31 13F TG THERAPEUTICS COM Call 100,000 -77.78 984 -80.30 n/a n/a n/a
2020-02-14 2019-12-31 13F TG THERAPEUTICS COM Call 450,000 4,995 n/a n/a n/a
2019-08-15 2019-06-30 13F/A TG THERAPEUTICS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2019-05-14 2019-03-31 13F TG THERAPEUTICS COM Call 1,025,100 8,242 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2025-08-14 2025-06-30 13F TG THERAPEUTICS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2025-05-15 2025-03-31 13F TG THERAPEUTICS COM Put 7,200 284 n/a n/a n/a
2024-08-14 2024-06-30 13F TG THERAPEUTICS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2024-05-15 2024-03-31 13F TG THERAPEUTICS COM Put 60,000 -45.21 913 -51.23 n/a n/a n/a
2024-02-14 2023-12-31 13F TG THERAPEUTICS COM Put 109,500 1,870 n/a n/a n/a
2023-05-15 2023-03-31 13F TG THERAPEUTICS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2023-02-14 2022-12-31 13F TG THERAPEUTICS COM Put 734,200 8,686 n/a n/a n/a
2022-11-14 2022-09-30 13F TG THERAPEUTICS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2022-08-15 2022-06-30 13F TG THERAPEUTICS COM Put 444,500 344.50 1,889 98.63 n/a n/a n/a
2022-05-16 2022-03-31 13F TG THERAPEUTICS COM Put 100,000 951 n/a n/a n/a
2021-02-16 2020-12-31 13F TG THERAPEUTICS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2020-11-16 2020-09-30 13F TG THERAPEUTICS COM Put 85,000 2,275 n/a n/a n/a
2020-05-14 2020-03-31 13F TG THERAPEUTICS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2020-02-14 2019-12-31 13F TG THERAPEUTICS COM Put 123,000 1,365 n/a n/a n/a
2019-08-15 2019-06-30 13F/A TG THERAPEUTICS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2019-05-14 2019-03-31 13F TG THERAPEUTICS COM Put 807,100 6,489 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.